Whether you are a founder seeking strategic capital, an institutional LP, or a corporate partner exploring collaboration — we are ready to listen and act.
By submitting you agree to our Privacy Policy. Your information will be handled with complete discretion and never shared with third parties.
✓
Message Received
Thank you for reaching out to MedLinks Capital. Our team will be in touch shortly.
Frequently Asked
Common Questions
What stage do you invest in?
We invest from Series A through pre-IPO, with a strong preference for Series B and C opportunities in companies with initial revenue traction and clinical proof-of-concept.
What is your typical investment size?
Initial investments range from $10M to $50M, with follow-on capital of up to $100M for exceptional performers where we hold conviction about the long-term opportunity.
How long does your review process take?
Initial response within 48 hours. First partner meeting typically within 2 weeks. Full investment committee review and term sheet, if progressing, within 60-90 days.
Do you invest outside the US?
Actively. We have invested in companies across the UK, EU, Israel, Australia, Canada, India, and APAC. Cross-border expansion is one of our most distinctive value-add capabilities.